Improved Net Protein Balance, Lean Mass, and Gene Expression Changes with Oxandrolone Treatment in the Severely Burned

Steven Wolf, Steven J. Thomas, Mohan R. Dasu, Arny A. Ferrando, David L. Chinkes, Robert R. Wolfe, David Herndon, Basil A. Pruit, William G. Cioffi, George M. Watkins, William C. Lineaweaver, Steven E. Wolf

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Objective: To determine the effects of the anabolic agent oxandrolone on muscle protein and gene expression in severely burned children. Summary Background Data: The authors previously showed that oxandrolone increased net muscle protein synthesis in emaciated burned patients receiving delayed treatment for severe burns. They hypothesized that similar effects would be seen in those treated early after burn. Methods: Thirty-two severely burned children were enrolled in a prospective randomized trial. Subjects underwent studies to assess leg protein net balance 5 days after the first excision and grafting procedure. Immediately after these studies, treatment with placebo (n = 18) or 0.1 mg/kg oxandrolone (n = 14) twice a day was started. One week after this, another net balance study was performed in each subject. Body weights and total body potassium counting were used to determine body compositional changes. Muscle biopsies were taken 1 week after treatment in oxandrolone subjects to examine gene expression changes with gene array (12,600 genes). Results: Protein net balance did not change in the placebo group, while oxandrolone-treated subjects had a significant improvement. Body weights and fat free mass significantly decreased in the placebo group, while no changes were found in the oxandrolone-treated subjects. Expression changes were seen in 14 genes in the oxandrolone group compared to placebo. Some of these included myosin light chain (+2.7-fold change), tubulin (+2.3), calmodulin (-2.3), and protein phosphatase I inhibitor (-2.8). Conclusions: Oxandrolone improves protein net balance and lean mass in the severely burned. These changes are associated with increased gene expression for functional muscle proteins.

Original languageEnglish (US)
Pages (from-to)801-811
Number of pages11
JournalAnnals of Surgery
Volume237
Issue number6
DOIs
StatePublished - Jun 2003

Fingerprint

Oxandrolone
Gene Expression
Muscle Proteins
Proteins
Placebos
Therapeutics
Body Weight
Genes
Anabolic Agents
Myosin Light Chains
Phosphoprotein Phosphatases
Calmodulin
Tubulin
Burns
Adipose Tissue
Leg
Potassium
Biopsy

ASJC Scopus subject areas

  • Surgery

Cite this

Improved Net Protein Balance, Lean Mass, and Gene Expression Changes with Oxandrolone Treatment in the Severely Burned. / Wolf, Steven; Thomas, Steven J.; Dasu, Mohan R.; Ferrando, Arny A.; Chinkes, David L.; Wolfe, Robert R.; Herndon, David; Pruit, Basil A.; Cioffi, William G.; Watkins, George M.; Lineaweaver, William C.; Wolf, Steven E.

In: Annals of Surgery, Vol. 237, No. 6, 06.2003, p. 801-811.

Research output: Contribution to journalArticle

Wolf, S, Thomas, SJ, Dasu, MR, Ferrando, AA, Chinkes, DL, Wolfe, RR, Herndon, D, Pruit, BA, Cioffi, WG, Watkins, GM, Lineaweaver, WC & Wolf, SE 2003, 'Improved Net Protein Balance, Lean Mass, and Gene Expression Changes with Oxandrolone Treatment in the Severely Burned', Annals of Surgery, vol. 237, no. 6, pp. 801-811. https://doi.org/10.1097/00000658-200306000-00008
Wolf, Steven ; Thomas, Steven J. ; Dasu, Mohan R. ; Ferrando, Arny A. ; Chinkes, David L. ; Wolfe, Robert R. ; Herndon, David ; Pruit, Basil A. ; Cioffi, William G. ; Watkins, George M. ; Lineaweaver, William C. ; Wolf, Steven E. / Improved Net Protein Balance, Lean Mass, and Gene Expression Changes with Oxandrolone Treatment in the Severely Burned. In: Annals of Surgery. 2003 ; Vol. 237, No. 6. pp. 801-811.
@article{e9d5b127c349480aa7da04917eccc697,
title = "Improved Net Protein Balance, Lean Mass, and Gene Expression Changes with Oxandrolone Treatment in the Severely Burned",
abstract = "Objective: To determine the effects of the anabolic agent oxandrolone on muscle protein and gene expression in severely burned children. Summary Background Data: The authors previously showed that oxandrolone increased net muscle protein synthesis in emaciated burned patients receiving delayed treatment for severe burns. They hypothesized that similar effects would be seen in those treated early after burn. Methods: Thirty-two severely burned children were enrolled in a prospective randomized trial. Subjects underwent studies to assess leg protein net balance 5 days after the first excision and grafting procedure. Immediately after these studies, treatment with placebo (n = 18) or 0.1 mg/kg oxandrolone (n = 14) twice a day was started. One week after this, another net balance study was performed in each subject. Body weights and total body potassium counting were used to determine body compositional changes. Muscle biopsies were taken 1 week after treatment in oxandrolone subjects to examine gene expression changes with gene array (12,600 genes). Results: Protein net balance did not change in the placebo group, while oxandrolone-treated subjects had a significant improvement. Body weights and fat free mass significantly decreased in the placebo group, while no changes were found in the oxandrolone-treated subjects. Expression changes were seen in 14 genes in the oxandrolone group compared to placebo. Some of these included myosin light chain (+2.7-fold change), tubulin (+2.3), calmodulin (-2.3), and protein phosphatase I inhibitor (-2.8). Conclusions: Oxandrolone improves protein net balance and lean mass in the severely burned. These changes are associated with increased gene expression for functional muscle proteins.",
author = "Steven Wolf and Thomas, {Steven J.} and Dasu, {Mohan R.} and Ferrando, {Arny A.} and Chinkes, {David L.} and Wolfe, {Robert R.} and David Herndon and Pruit, {Basil A.} and Cioffi, {William G.} and Watkins, {George M.} and Lineaweaver, {William C.} and Wolf, {Steven E.}",
year = "2003",
month = "6",
doi = "10.1097/00000658-200306000-00008",
language = "English (US)",
volume = "237",
pages = "801--811",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Improved Net Protein Balance, Lean Mass, and Gene Expression Changes with Oxandrolone Treatment in the Severely Burned

AU - Wolf, Steven

AU - Thomas, Steven J.

AU - Dasu, Mohan R.

AU - Ferrando, Arny A.

AU - Chinkes, David L.

AU - Wolfe, Robert R.

AU - Herndon, David

AU - Pruit, Basil A.

AU - Cioffi, William G.

AU - Watkins, George M.

AU - Lineaweaver, William C.

AU - Wolf, Steven E.

PY - 2003/6

Y1 - 2003/6

N2 - Objective: To determine the effects of the anabolic agent oxandrolone on muscle protein and gene expression in severely burned children. Summary Background Data: The authors previously showed that oxandrolone increased net muscle protein synthesis in emaciated burned patients receiving delayed treatment for severe burns. They hypothesized that similar effects would be seen in those treated early after burn. Methods: Thirty-two severely burned children were enrolled in a prospective randomized trial. Subjects underwent studies to assess leg protein net balance 5 days after the first excision and grafting procedure. Immediately after these studies, treatment with placebo (n = 18) or 0.1 mg/kg oxandrolone (n = 14) twice a day was started. One week after this, another net balance study was performed in each subject. Body weights and total body potassium counting were used to determine body compositional changes. Muscle biopsies were taken 1 week after treatment in oxandrolone subjects to examine gene expression changes with gene array (12,600 genes). Results: Protein net balance did not change in the placebo group, while oxandrolone-treated subjects had a significant improvement. Body weights and fat free mass significantly decreased in the placebo group, while no changes were found in the oxandrolone-treated subjects. Expression changes were seen in 14 genes in the oxandrolone group compared to placebo. Some of these included myosin light chain (+2.7-fold change), tubulin (+2.3), calmodulin (-2.3), and protein phosphatase I inhibitor (-2.8). Conclusions: Oxandrolone improves protein net balance and lean mass in the severely burned. These changes are associated with increased gene expression for functional muscle proteins.

AB - Objective: To determine the effects of the anabolic agent oxandrolone on muscle protein and gene expression in severely burned children. Summary Background Data: The authors previously showed that oxandrolone increased net muscle protein synthesis in emaciated burned patients receiving delayed treatment for severe burns. They hypothesized that similar effects would be seen in those treated early after burn. Methods: Thirty-two severely burned children were enrolled in a prospective randomized trial. Subjects underwent studies to assess leg protein net balance 5 days after the first excision and grafting procedure. Immediately after these studies, treatment with placebo (n = 18) or 0.1 mg/kg oxandrolone (n = 14) twice a day was started. One week after this, another net balance study was performed in each subject. Body weights and total body potassium counting were used to determine body compositional changes. Muscle biopsies were taken 1 week after treatment in oxandrolone subjects to examine gene expression changes with gene array (12,600 genes). Results: Protein net balance did not change in the placebo group, while oxandrolone-treated subjects had a significant improvement. Body weights and fat free mass significantly decreased in the placebo group, while no changes were found in the oxandrolone-treated subjects. Expression changes were seen in 14 genes in the oxandrolone group compared to placebo. Some of these included myosin light chain (+2.7-fold change), tubulin (+2.3), calmodulin (-2.3), and protein phosphatase I inhibitor (-2.8). Conclusions: Oxandrolone improves protein net balance and lean mass in the severely burned. These changes are associated with increased gene expression for functional muscle proteins.

UR - http://www.scopus.com/inward/record.url?scp=0038452611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038452611&partnerID=8YFLogxK

U2 - 10.1097/00000658-200306000-00008

DO - 10.1097/00000658-200306000-00008

M3 - Article

VL - 237

SP - 801

EP - 811

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 6

ER -